Brief: 3Sbio Says Recombinant Human Thrombopoietin Injection Approved For Pediatric ITP Indication
12/04/2024 16:59
April 12 (Reuters) - 3SBio Inc 1530.HK :
* RECOMBINANT HUMAN THROMBOPOIETIN INJECTION OF 3SBIO
APPROVED FOR
PEDIATRIC ITP INDICATION BY NMPA
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))